Jason Pontin is a general partner at DCVC, investing in computational biology and chemistry and leading its communications team. He co-founded Totus Medicines in 2020 and previously was a senior partner and senior advisor at Flagship Pioneering. From 2004 to 2017, he was editor in chief and publisher of MIT Technology Review, where he also founded MIT Solve and advised MIT president Susan Hockfield. He earlier founded and edited The Acumen Journal of Life Sciences, edited Red Herring, and wrote for publications including The New York Times.
Jason Pontin is a general partner at DCVC, investing in computational biology and chemistry and leading its communications team. He co-founded Totus Medicines in 2020 and previously was a senior partner and senior advisor at Flagship Pioneering. From 2004 to 2017, he was editor in chief and publisher of MIT Technology Review, where he also founded MIT Solve and advised MIT president Susan Hockfield. He earlier founded and edited The Acumen Journal of Life Sciences, edited Red Herring, and wrote for publications including The New York Times.
Career
General Partner at DCVC until PresentJoined DCVC in 2021.